Bovine jugular vein conduit for right ventricular outflow tract reconstruction: evaluation of risk factors for mid-term outcome
- PMID: 16996925
- DOI: 10.1016/j.athoracsur.2006.04.071
Bovine jugular vein conduit for right ventricular outflow tract reconstruction: evaluation of risk factors for mid-term outcome
Abstract
Background: The bovine jugular vein conduit (Contegra [Medtronic, Inc, Minneapolis, MN]) is one option for right ventricular outflow tract reconstruction. We examined the effect of patient age, conduit size, hemodynamics, and cardiac malformation on early and mid-term outcome.
Methods: Seventy-eight bovine jugular vein implantations were performed over 5 years. Follow-up averaged 31 +/- 17 months. Risk factor and adverse event analyses for graft dysfunction were performed by multivariate logistic regression and Kaplan-Meier analysis.
Results: There was no early mortality. Two late deaths occurred after 9 and 15 months. Early postoperative echocardiography revealed bovine jugular vein regurgitation greater than 2+ in 10 patients, all of which had conduit dilatation, had received a 12-mm conduit, and had a right-ventricular-to-left ventricular pressure ratio greater than 0.6. Two additional patients had severe conduit incompetence develop at the 2-year follow-up. During follow-up, mean gradients increased from 15 to 23 mm Hg (p = 0.03) and stenosis at the distal anastomosis occurred in 25% of patients. Percutaneous interventions were performed in 19 patients (24.4%). Conduit exchange was required in 10 patients (12.8%) after a mean of 14.9 months for severe graft incompetence (8 patients) and progressive supravalvular stenosis (2 patients). Freedom from reoperation was 77.6% and 59.3% at 1 and 4 years for patients less than 1 year of age compared with 93.5% and 87.4% for patients older than 1 year of age (p < 0.001). Risk factors for reoperation were age less than 1 year, correction of truncus arteriosus, conduit size of 12 mm, and persistently elevated right-ventricular-to-left ventricular pressure ratio greater than 0.6 (p = 0.001 each).
Conclusions: Bovine jugular vein implantation is associated with low reoperation and acceptable reintervention rate in patients older than 1 year of age. In infants with persistently elevated right ventricular pressure, reoperation rate was high and had to be compared with other established surgical options.
Similar articles
-
Valved bovine jugular vein conduits for right ventricular outflow tract reconstruction in children: an attractive alternative to pulmonary homograft.Ann Thorac Surg. 2006 Sep;82(3):909-16. doi: 10.1016/j.athoracsur.2006.03.008. Ann Thorac Surg. 2006. PMID: 16928507
-
Right ventricular outflow tract reconstruction using Contegra valved conduit: natural history and conduit performance under pressure.Eur J Cardiothorac Surg. 2006 Mar;29(3):397-405. doi: 10.1016/j.ejcts.2005.11.040. Epub 2006 Jan 24. Eur J Cardiothorac Surg. 2006. PMID: 16439155
-
Early results of the bovine jugular vein graft used for reconstruction of the right ventricular outflow tract.Ann Thorac Surg. 2005 Feb;79(2):618-24. doi: 10.1016/j.athoracsur.2004.07.081. Ann Thorac Surg. 2005. PMID: 15680847 Clinical Trial.
-
Contegra conduit: current outcomes and concerns.Expert Rev Cardiovasc Ther. 2006 Sep;4(5):721-30. doi: 10.1586/14779072.4.5.721. Expert Rev Cardiovasc Ther. 2006. PMID: 17081094 Review.
-
Outcomes in patients with interrupted aortic arch and associated anomalies: a 20-year experience.Eur J Cardiothorac Surg. 2006 May;29(5):666-73; discussion 673-4. doi: 10.1016/j.ejcts.2006.01.060. Epub 2006 Apr 12. Eur J Cardiothorac Surg. 2006. PMID: 16626964 Review.
Cited by
-
Biofabrication in Congenital Cardiac Surgery: A Plea from the Operating Theatre, Promise from Science.Micromachines (Basel). 2021 Mar 21;12(3):332. doi: 10.3390/mi12030332. Micromachines (Basel). 2021. PMID: 33800971 Free PMC article. Review.
-
Current development of bovine jugular vein conduit for right ventricular outflow tract reconstruction.Front Bioeng Biotechnol. 2022 Aug 4;10:920152. doi: 10.3389/fbioe.2022.920152. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35992331 Free PMC article. Review.
-
Current status of the mechanical valve and bioprosthesis in Japan.J Artif Organs. 2008;11(2):53-9. doi: 10.1007/s10047-008-0409-4. Epub 2008 Jul 6. J Artif Organs. 2008. PMID: 18604609 Review.
-
The Contegra conduit: Late outcomes in right ventricular outflow tract reconstruction.Ann Pediatr Cardiol. 2012 Jan;5(1):27-33. doi: 10.4103/0974-2069.93706. Ann Pediatr Cardiol. 2012. PMID: 22529597 Free PMC article.
-
Mid-term outcomes of Contegra implantation for the reconstruction of the right ventricular outflow tract to proximal branch pulmonary arteries: Japan multicentre study.Interact Cardiovasc Thorac Surg. 2021 Jul 26;33(2):227-236. doi: 10.1093/icvts/ivab075. Interact Cardiovasc Thorac Surg. 2021. PMID: 33755119 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical